MedTrace Logo

The Effectiveness of Transcutaneous Electrical Nerve Stimulation After Thoracic Surgery

NCT04879108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-05-10

No results posted yet for this study

Summary

The purpose of this randomised and controlled study is to investigate the effects of transcutaneous electrical nerve stimulation combined with physiotherapy and rehabilitation program on pulmonary function and functional exercise capacity.

Conditions

  • Thoracic
  • Surgery
  • Pain
  • Pulmonary Function
  • Functional Capacity

Interventions

OTHER

Physiotherapy rehabilitation and Transcutaneous Electrical Nerve Stimulation

Physiotherapy rehabilitation and Transcutaneous Electrical Nerve Stimulation (TENS) group received TENS therapy in addition to physiotherapy rehabilitation after thoracic surgery. Physiotherapy and rehabilitation program was started after surgery and it was performed for 30 min, twice a day, 5 day a week. The program was included respiratory and posture exercises, coughing, enhancing mobility. Transcutaneous Electrical Nerve Stimulation was performed with the a 2-channel portable TENS device and using disposable electrodes. TENS applied on both sides of the incision line. After surgery, TENS was performed before the Physiotherapy and Rehabilitation for 30 min, twice a day, 5 day a week. Patients were evaluated before the surgery and the end of postoperative 5th day.

OTHER

Physiotherapy Rehabilitation

Physiotherapy and Rehabilitation was performed for 5 days after surgery, twice a day, for 30 min, 5 day a week after thoracic surgery. The program was included respiratory and posture exercises, coughing, enhancing mobility. Patients were evaluated before the surgery and the end of postoperative 5th day.

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Aysel Yildiz Ozer, PT, PhD · Marmara University

  • Nilgun Gurses, Prof · Bezmialem Vakif University

  • Alper Toker, Prof · Istanbul University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-20
Primary Completion
2011-04-30
Completion
2011-09-05

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04879108 on ClinicalTrials.gov